Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) and SmartRent (NYSE:SMRT – Get Free Report) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.
Insider and Institutional Ownership
5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 59.4% of SmartRent shares are held by institutional investors. 6.4% of Firefly Neuroscience shares are held by company insiders. Comparatively, 1.9% of SmartRent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Risk and Volatility
Firefly Neuroscience has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500. Comparatively, SmartRent has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Firefly Neuroscience | $783,000.00 | 14.40 | -$10.46 million | ($2.09) | -0.38 |
| SmartRent | $174.88 million | 1.88 | -$33.64 million | ($0.36) | -4.82 |
Firefly Neuroscience has higher earnings, but lower revenue than SmartRent. SmartRent is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Firefly Neuroscience and SmartRent’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Firefly Neuroscience | -2,705.88% | -319.00% | -191.27% |
| SmartRent | -45.45% | -15.10% | -10.36% |
Analyst Recommendations
This is a summary of recent ratings for Firefly Neuroscience and SmartRent, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
| SmartRent | 1 | 3 | 0 | 0 | 1.75 |
SmartRent has a consensus target price of $1.45, suggesting a potential downside of 16.43%. Given SmartRent’s stronger consensus rating and higher probable upside, analysts plainly believe SmartRent is more favorable than Firefly Neuroscience.
Summary
SmartRent beats Firefly Neuroscience on 8 of the 13 factors compared between the two stocks.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
About SmartRent
SmartRent, Inc., an enterprise software company, provides an integrated smart home operating system to residential property owners and operators, homebuilders, institutional home buyers, developers, and residents in the United States. The company’s products and solutions include smart apartments and homes, access control for buildings, common areas, and rental units, asset protection and monitoring, parking management, self-guided tours, and community and resident Wi-Fi. It also offers professional services to customers, which include training, installation, and support services. The company was founded in 2017 and is headquartered in Scottsdale, Arizona.
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
